Pharmaceutical company settles civil allegations for $2.8M
Published: March 29,2012
MADISON — A Mississippi-based pharmaceutical company has agreed to pay $2.8 million to resolve civil allegations that the manufacturer falsely marketed skin products to receive government funding.
U.S. Attorney John M. Bales said yesterday Cypress Pharmaceutical Inc., a subsidiary and CEO Max Draughn will pay $1.6 million to the military’s TRICARE program and $1.2 million to state Medicaid programs.
The government alleges that Cypress subsidiary Hawthorne Pharmaceuticals Inc. claimed that three skin products carried the Food and Drug Administration’s “safe and effective” designation when the treatments didn’t. The government also claims the regulatory status of the products was misrepresented.
Bales says a whistleblower who sued under the False Claims Act received $300,000 as part of the settlement.
An official for Madison-based Cypress didn’t immediately return a phone call seeking comment.
To sign up for Mississippi Business Daily Updates, click here.
FOLLOW THE MBJ ON TWITTERMy Tweets
Twang & Tourism: The Country Music Trail
Top Posts & Pages
- Brandon man hauls in record 756-pound alligator
- Officials set hunting dates for birds; expands dove season by 20 days
- McDaniel delays decision on whether to appeal dismissal of lawsuit
- FLIPPING OUT — Flipping houses is popular in much of the country, but in Mississippi ...
- Is cotton looking too good? Farmers facing weaker prices
- More than a dozen school districts sue state over funding
- REVVING UP — Motorcars of Jackson is preparing to open its first-ever showroom on I-55
- Bryant issues executive order to establish Delta water task force
- Jackson to get C Spire's high-speed internet